Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

NCT01746849 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Multiple Myeloma
Myelodysplastic Syndrome
Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: Palifermin
BIOLOGICAL: Lupron
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: Total-Body Irradiation (TBI)
DRUG: Thiotepa
DRUG: Cyclophosphamide
DRUG: Degarelix

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Swedish Orphan Biovitrum